Shares of indie Semiconductor surged 18.1% to $4.05 after the automotive chipmaker posted second-quarter results that showed the clearest signs yet that its long-promised growth inflection is materializing. The question now: whether accelerating revenue can outrun a balance sheet still weighed down by $416 million in debt and persistent operating losses.
Revenue Grew 24%, and the Next Quarter Looks Even Stronger
Q2 revenue hit $64.0 million, up 24% from $51.6 million a year earlier. More important, Q3 guidance of $67 million to $73 million implies roughly 30% year-over-year growth at the midpoint and a 9% sequential jump — a pace that flips the narrative from stagnation to acceleration. Design wins with Volvo's Tier 1 supplier, Chinese automakers, and robotics firms are fueling the ramp. Investors are betting the growth curve has durably steepened.
Losses Are Narrowing, But Profitability Remains Elusive
GAAP operating loss shrank to $35.1 million from $43.0 million, and the non-GAAP figure fell to $8.9 million from $14.5 million. That $5.6 million improvement in adjusted losses on $12.4 million of incremental revenue shows operating leverage is emerging. Yet both GAAP and adjusted earnings remain negative , meaning the company still spends more than it earns before even paying interest on its debt. Management guided Q3 operating expenses down to $37 million , signaling continued cost discipline.
The Balance Sheet Is the Real Wild Card
Cash stood at $139 million at quarter-end, down $6.5 million in six months.
Total debt climbed to roughly $416 million , partly due to a recent refinancing that extended maturities to 2031 but added leverage. A pending $135 million divestiture of its Wuxi subsidiary is progressing through Chinese regulatory review — if it closes, it would give indie a meaningful cash cushion. But Wuxi currently accounts for roughly 38% of consolidated revenue , so shedding it will reshape the company's top line overnight.
The Market Is Pricing Hope, Not Proof At a $778 million market cap, indie trades at roughly 3× its projected $266 million 2026 revenue — not absurd for a fast-growing chip company, but aggressive for one that hasn't earned a dollar of profit. Analyst consensus targets sit near $6.11 , well above today's price. The gap between that optimism and indie's cash-burning reality is where the real investment debate lives.